Portfolio Companies News
April 20, 2021BONESUPPORT awarded Synthetic Impla...
—– This press release has been modified to comply with the Premier IR guidelines —– Lund, Sweden, 13.00 CET, 20 April 2021 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, has been awarded a group purchasing agreement for Synthe... read more
April 20, 2021Pulmonx to Report First Quarter 202...
REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2021 after the close of trading on Tuesday,... read more
April 20, 2021Nordic Nanovector ASA - Share capit...
Oslo, Norway, 20 April 2021 Reference is made to the stock exchange announcement on 12 April 2021 regarding the final result of Nordic Nanovector ASA's (OSE: NANOV) (the "Company") the repair offering where 2,699,280 new shares (the "New Shares") were allocated at a subscription price of NOK 22.... read more
April 20, 2021Vicore Pharma to host Key Opinion L...
2021-04-20 KOL webinar being held on Wednesday, April 28[th] @ 14:00 CET (8 am EST) Gothenburg, April 20, 2021 – Vicore Pharma Holding AB (publ) (“Vicore”), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary fibrosis (IPF), today... read more
April 16, 2021Oncopeptides submits application fo...
STOCKHOLM — April 16, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has submitted an application to the European Medicines Agency,... read more
February 12, 2021Q4 2020 General Market Overview
Since the start in 1996, HealthCap funds have invested in 119 portfolio companies.
46 of the portfolio companies have been taken public on nine different markets.
27 of the portfolio companies pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 12 companies with a valuation of USD 1 billion or more.